Analysis of human brain tissue derived from DBS surgery

Abstract Background Transcriptomic and proteomic profiling of human brain tissue is hindered by the availability of fresh samples from living patients. Postmortem samples usually represent the advanced disease stage of the patient. Furthermore, the postmortem interval can affect the transcriptomic a...

Full description

Bibliographic Details
Main Authors: Salla M. Kangas, Jaakko Teppo, Maija J. Lahtinen, Anu Suoranta, Bishwa Ghimire, Pirkko Mattila, Johanna Uusimaa, Markku Varjosalo, Jani Katisko, Reetta Hinttala
Format: Article
Language:English
Published: BMC 2022-04-01
Series:Translational Neurodegeneration
Subjects:
Online Access:https://doi.org/10.1186/s40035-022-00297-y
_version_ 1828378810696859648
author Salla M. Kangas
Jaakko Teppo
Maija J. Lahtinen
Anu Suoranta
Bishwa Ghimire
Pirkko Mattila
Johanna Uusimaa
Markku Varjosalo
Jani Katisko
Reetta Hinttala
author_facet Salla M. Kangas
Jaakko Teppo
Maija J. Lahtinen
Anu Suoranta
Bishwa Ghimire
Pirkko Mattila
Johanna Uusimaa
Markku Varjosalo
Jani Katisko
Reetta Hinttala
author_sort Salla M. Kangas
collection DOAJ
description Abstract Background Transcriptomic and proteomic profiling of human brain tissue is hindered by the availability of fresh samples from living patients. Postmortem samples usually represent the advanced disease stage of the patient. Furthermore, the postmortem interval can affect the transcriptomic and proteomic profiles. Therefore, fresh brain tissue samples from living patients represent a valuable resource of metabolically intact tissue. Implantation of deep brain stimulation (DBS) electrodes into the human brain is a neurosurgical treatment for, e.g., movement disorders. Here, we describe an improved approach to collecting brain tissues from surgical instruments used in implantation of DBS device for transcriptomics and proteomics analyses. Methods Samples were extracted from guide tubes and recording electrodes used in routine DBS implantation procedure to treat patients with Parkinson’s disease, genetic dystonia and tremor. RNA sequencing was performed in tissues extracted from the recording microelectrodes and liquid chromatography-mass spectrometry (LC-MS) performed in tissues from guide tubes. To assess the performance of the current approach, the obtained datasets were compared with previously published datasets representing brain tissues. Results Altogether, 32,034 RNA transcripts representing the unique Ensembl gene identifiers were detected from eight samples representing both hemispheres of four patients. By using  LC-MS, we identified 734 unique proteins from 31 samples collected from 14 patients. The datasets are available in the BioStudies database (accession number S-BSST667). Our results indicate that surgical instruments used in DBS installation retain brain material sufficient for protein and gene expression studies. Comparison with previously published datasets obtained with similar approach proved the robustness and reproducibility of the protocol. Conclusions The instruments used during routine DBS surgery are a useful source for obtaining fresh brain tissues from living patients. This approach overcomes the issues that arise from using postmortem tissues, such as the effect of postmortem interval on transcriptomic and proteomic landscape of the brain, and can be used for studying molecular aspects of DBS-treatable diseases.
first_indexed 2024-12-10T03:29:41Z
format Article
id doaj.art-01bcf4d50e8f47fa87519123d6cba3ff
institution Directory Open Access Journal
issn 2047-9158
language English
last_indexed 2024-12-10T03:29:41Z
publishDate 2022-04-01
publisher BMC
record_format Article
series Translational Neurodegeneration
spelling doaj.art-01bcf4d50e8f47fa87519123d6cba3ff2022-12-22T02:03:51ZengBMCTranslational Neurodegeneration2047-91582022-04-0111111610.1186/s40035-022-00297-yAnalysis of human brain tissue derived from DBS surgerySalla M. Kangas0Jaakko Teppo1Maija J. Lahtinen2Anu Suoranta3Bishwa Ghimire4Pirkko Mattila5Johanna Uusimaa6Markku Varjosalo7Jani Katisko8Reetta Hinttala9PEDEGO Research Unit, University of OuluInstitute of Biotechnology, HiLIFE Helsinki Institute of Life Science, University of HelsinkiMedical Research Center, Oulu University Hospital, University of OuluInstitute for Molecular Medicine Finland (FIMM), HiLIFE Helsinki Institute of Life Science, University of HelsinkiInstitute for Molecular Medicine Finland (FIMM), HiLIFE Helsinki Institute of Life Science, University of HelsinkiInstitute for Molecular Medicine Finland (FIMM), HiLIFE Helsinki Institute of Life Science, University of HelsinkiPEDEGO Research Unit, University of OuluInstitute of Biotechnology, HiLIFE Helsinki Institute of Life Science, University of HelsinkiMedical Research Center, Oulu University Hospital, University of OuluPEDEGO Research Unit, University of OuluAbstract Background Transcriptomic and proteomic profiling of human brain tissue is hindered by the availability of fresh samples from living patients. Postmortem samples usually represent the advanced disease stage of the patient. Furthermore, the postmortem interval can affect the transcriptomic and proteomic profiles. Therefore, fresh brain tissue samples from living patients represent a valuable resource of metabolically intact tissue. Implantation of deep brain stimulation (DBS) electrodes into the human brain is a neurosurgical treatment for, e.g., movement disorders. Here, we describe an improved approach to collecting brain tissues from surgical instruments used in implantation of DBS device for transcriptomics and proteomics analyses. Methods Samples were extracted from guide tubes and recording electrodes used in routine DBS implantation procedure to treat patients with Parkinson’s disease, genetic dystonia and tremor. RNA sequencing was performed in tissues extracted from the recording microelectrodes and liquid chromatography-mass spectrometry (LC-MS) performed in tissues from guide tubes. To assess the performance of the current approach, the obtained datasets were compared with previously published datasets representing brain tissues. Results Altogether, 32,034 RNA transcripts representing the unique Ensembl gene identifiers were detected from eight samples representing both hemispheres of four patients. By using  LC-MS, we identified 734 unique proteins from 31 samples collected from 14 patients. The datasets are available in the BioStudies database (accession number S-BSST667). Our results indicate that surgical instruments used in DBS installation retain brain material sufficient for protein and gene expression studies. Comparison with previously published datasets obtained with similar approach proved the robustness and reproducibility of the protocol. Conclusions The instruments used during routine DBS surgery are a useful source for obtaining fresh brain tissues from living patients. This approach overcomes the issues that arise from using postmortem tissues, such as the effect of postmortem interval on transcriptomic and proteomic landscape of the brain, and can be used for studying molecular aspects of DBS-treatable diseases.https://doi.org/10.1186/s40035-022-00297-yDeep brain stimulationMovement disordersBrainProteomicsTranscriptomicsRNA sequencing
spellingShingle Salla M. Kangas
Jaakko Teppo
Maija J. Lahtinen
Anu Suoranta
Bishwa Ghimire
Pirkko Mattila
Johanna Uusimaa
Markku Varjosalo
Jani Katisko
Reetta Hinttala
Analysis of human brain tissue derived from DBS surgery
Translational Neurodegeneration
Deep brain stimulation
Movement disorders
Brain
Proteomics
Transcriptomics
RNA sequencing
title Analysis of human brain tissue derived from DBS surgery
title_full Analysis of human brain tissue derived from DBS surgery
title_fullStr Analysis of human brain tissue derived from DBS surgery
title_full_unstemmed Analysis of human brain tissue derived from DBS surgery
title_short Analysis of human brain tissue derived from DBS surgery
title_sort analysis of human brain tissue derived from dbs surgery
topic Deep brain stimulation
Movement disorders
Brain
Proteomics
Transcriptomics
RNA sequencing
url https://doi.org/10.1186/s40035-022-00297-y
work_keys_str_mv AT sallamkangas analysisofhumanbraintissuederivedfromdbssurgery
AT jaakkoteppo analysisofhumanbraintissuederivedfromdbssurgery
AT maijajlahtinen analysisofhumanbraintissuederivedfromdbssurgery
AT anusuoranta analysisofhumanbraintissuederivedfromdbssurgery
AT bishwaghimire analysisofhumanbraintissuederivedfromdbssurgery
AT pirkkomattila analysisofhumanbraintissuederivedfromdbssurgery
AT johannauusimaa analysisofhumanbraintissuederivedfromdbssurgery
AT markkuvarjosalo analysisofhumanbraintissuederivedfromdbssurgery
AT janikatisko analysisofhumanbraintissuederivedfromdbssurgery
AT reettahinttala analysisofhumanbraintissuederivedfromdbssurgery